928 research outputs found
The Role of ABO Blood Type in Thrombosis Scoring Systems
In addition to their major role in transfusion medicine, there is increasing evidence that ABO blood group antigens (complex carbohydrate molecules widely expressed on the surface of red blood cells and several other cell types) are implicated in the development of a wide array of pathologic conditions. In particular, intense research has been dedicated over the last 50 years to the study of the association between non-O blood type and the risk of developing cardiovascular disorders. Several pathways have been hypothesized to explain this relationship, the most reasonable implying the influence of the ABO blood group on circulating plasma levels of von Willebrand factor, factor VIII, and several inflammatory cytokines. This narrative review summarizes the current knowledge on the role of ABO antigens in both venous and arterial thromboses, focusing on their association with clinical scoring systems evaluating thrombotic risk
The management of a blood donor bitten by a snake
The worldwide burden of snakebite is high and venomous snakes are found in many regions of the world and are a threat to public health. In Italy, for instance, viper bites are an infrequent but not negligible event. Although people who have been bitten by a snake rarely wish to donate blood within a "short" time, it is however important to evaluate their eligibility to donate blood or blood components as their donation could be a problem for donor management, especially if a specific policy is not in place. The aim of this manuscript is to summarise the worldwide existing donor deferral policy for snakebites and to provide some indications in order to facilitate decision-making and to guarantee maximum safety for the donors as well as for the recipients
Human T-lymphotropic virus and transfusion safety. Does one size fit all?
Human T-cell leukemia viruses (HTLV-1 and HTLV-2) are associated with a variety of human diseases, including some severe ones. Transfusion transmission of HTLV
through cellular blood components is undeniable. HTLV screening of blood donations became mandatory in different countries to improve the safety of blood
supplies. In Japan and Europe, most HTLV-infected donors are HTLV-1 positive, whereas in the United States a higher prevalence of HTLV-2 is reported. Many
industrialized countries have also introduced universal leukoreduction of blood components, and pathogen inactivation technologies might be another effective
preventive strategy, especially if and when generalized to all blood cellular products. Considering all measures available to minimize HTLV blood transmission, the
question is what would be the most suitable and costeffective strategy to ensure a high level of blood safety regarding these viruses, considering that there is no
solution that can be deemed optimal for all countries
The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity
Background & aims: The metabolic and functional characteristics related to sarcopenic obesity have not been thoroughly explored in the earlier stages of the aging process. The aim of the present study was to examine the phenotype of sarcopenic obesity, in terms of lean body mass, muscle strength and quality, in adult women with and without the Metabolic Syndrome (MetS), and its relationship with the features of myosteatosis. Methods: Study participants were enrolled at the Sapienza University, Rome, Italy. Body composition was assessed by DXA. The Handgrip strength test (HGST) was performed. HGST was normalized to arm lean mass to indicate muscle quality; intermuscular adipose tissue (IMAT) and intramyocellular lipid content (IMCL) were measured by magnetic resonance imaging and spectroscopy, as indicators of myosteatosis. Different indices of sarcopenia were calculated, based on appendicular lean mass (ALM, kg) divided by height squared, or weight. The NCEP-ATPIII criteria were used to diagnose the MetS. HOMA-IR was calculated. The physical activity level (PAL) was assessed through the IPAQ questionnaire. Results: 54 women (age: 48 ± 14 years, BMI: 37.9 ± 5.4 kg/m 2 ) were included. 54% had the MetS (metabolically unhealthy, MUO). HGST/arm lean mass was lower in MUO women than women without the MetS (6.3 ± 1.8 vs. 7.8 ± 1.6, p = 0.03). No differences emerged in terms of absolute ALM (kg) or other indices of sarcopenia (ALM/h 2 or ALM/weight) between metabolically healthy (MHO) vs. MUO women (p > 0.05). Muscle quality was negatively associated with HOMA-IR (p = 0.02), after adjustment for age, body fat, hs-CRP levels, and PAL. IMAT, but not IMCL, was significantly higher in obese women with the MetS compared to women without the MetS (p > 0.05). No association emerged between HGST/arm lean mass and IMAT or IMCL when HOMA-IR was included in the models. Conclusion: Insulin resistance, and not sarcopenia or myosteatosis per se, was associated with muscle weakness, resulting in the phenotype of âdynapenic obesityâ in middle-aged women with the metabolic syndrome
Leptin Enhances, via AP-1, Expression of Aromatase in the MCF-7 Cell Line *
Leptin, a product of adipocytes, is involved in the regulation of body weight and results strongly correlated to body fat content. An excess of fat mass represents a breast cancer risk factor particularly in postmenopausal women, where estrogen production by adipose tissue through its own aromatase activity stimulates tumor progression. Leptin stimulates estrogen production through the increase of aromatase expression and activity in human luteinized granulosa cells and adipose stromal cells. In the present study, we have examined the possible link that exists between leptin and breast cancer, focusing our attention on the direct effect of leptin on aromatase activity, which may enhance estrogen production and induce tumor cell growth stimulation. We have shown that leptin enhances aromatase mRNA expression, aromatase content, and its enzymatic activity in MCF-7. Aromatase expression appears to be regulated by tissue-specific promoter. It has been demonstrated that promoters II and 1.3 are the major promoters that drive aromatase expression in MCF-7. Transient transfection experiments using vector containing human aromatase promoters II and 1.3 sequence fused with luciferase reporter gene demonstrated that leptin is able to activate this promoter. In the presence of either mitogen-activated protein kinase inhibitor PD 98059 or ERK2 dominant negative as well as in the presence of STAT3 dominant negative, the stimulatory effects of leptin on aromatase promoter, enzymatic activity, and aromatase protein content were inhibited. Functional studies of mutagenesis and electrophoretic mobility shift assay revealed that the AP-1 motif is important in determining the up-regulatory effects induced by leptin on aromatase expression in MCF-7
A Review on the Antimicrobial Activity of Schiff Bases: Data Collection and Recent Studies
Schiff bases (SBs) have extensive applications in different fields such as analytical, inorâ
ganic and organic chemistry. They are used as dyes, catalysts, polymer stabilizers, luminescence
chemosensors, catalyzers in the fixation of CO2 biolubricant additives and have been suggested for
solar energy applications as well. Further, a wide range of pharmacological and biological applicaâ
tions, such as antimalarial, antiproliferative, analgesic, antiâinflammatory, antiviral, antipyretic, anâ
tibacterial and antifungal uses, emphasize the need for SB synthesis. Several SBs conjugated with
chitosan have been studied in order to enhance the antibacterial activity of chitosan. Moreover, the
use of the nanoparticles of SBs may improve their antimicrobial effects. Herein, we provide an anaâ
lytical overview of the antibacterial and antifungal properties of SBs and chitosanâbased SBs as well
as SBsâfunctionalized nanoparticles. The most relevant and recent literature was reviewed for this
purpose
Antimicrobial and antioxidant properties and quantitative screening of phytochemicals of Fraxinus excelsior L. and Eschscholtzia californica Cham. mother tinctures
The antioxidant and antimicrobial activities of Fraxinus excelsior L.
and Eschscholtzia californica Cham. mother tinctures against a
range of foodborne bacteria were investigated to determine the
major components and to analyse the action spectrum and antimicrobial effectiveness of the extracts. Results demonstrated a significant antioxidant activity of Fraxinus excelsior L. and a lower
activity of Eschscholtzia californica Cham. and a good chemical
phenolic composition with the highest content of flavonoids. The
Fraxinus excelsior L. and Eschscholtzia californica Cham. mother
tinctures demonstrated a middle-high antimicrobial activity
against, respectively, 66.67% and 43.33% of all tested bacteria.
The inhibitory activity showed a moderate effect on the growth
of the sensitive strains in presence of extracts minimum inhibitory
concentration. The synergistic actions of bioactive compounds
detected in the extracts might be on the basis of antioxidant and
biological activities observed and should be used in pharmaceutical, food preservation, alternative medicine and natural therapies
fields
Convalescent plasma. New evidence for an old therapeutic tool?
Passive immunisation for the prevention and treatment of human infectious diseases can be traced back to the 20th century. The recent Ebola virus outbreak
in West Africa has turned the spotlight onto the possible use of convalescent whole blood and convalescent plasma in the treatment of infectious diseases because
they are the only therapeutic strategy available in some cases, given the unavailability of vaccines, drugs or other speciïŹc treatments. Convalescent blood products could be a valid option in the treatment/prophylaxis of several infectious diseases both in association with other drugs/preventive measures and as the only therapy
when a speciïŹc treatment is not available. However, there are still some issues to consider in determining the advisability of implementing a large-scale convalescent
plasma transfusion programm
Benzothiazole-Containing Analogues of Triclocarban with Potent Antibacterial Activity
Triclocarban (TCC) is a polychlorinated, aromatic, antimicrobial agent commercially used since the 1950s in personal care products for the prevention of spoilage and infections. Humans are frequently exposed to TCC due to its widespread use, leading to its substantial release into the aquatic environment. With the recent ban of TCC from some personal care products, implemented in 2016, many replacement antimicrobial compounds have been studied by researchers. Herein, we report the synthesis and biological activity of a series of diarylureas, analogues of TCC that bear the benzothiazole nucleus as one of the two aryl moieties. Among the studied compounds, 2bF and 2eC showed the highest antimicrobial activity against Staphylococcus aureus, being also more active than TCC, with MIC values of 8 ”g/mL versus 16 ”g/mL of TCC. Moreover, compound 2bB was much more active than TCC against Enterococcus faecalis, a Gram-positive bacterium that is, unfortunately, strongly responsible for nosocomial infections. Finally, interesting results were found for compound 2bG that, even though less active than the others, exerts an interesting bactericidal action
- âŠ